0000899243-17-012930.txt : 20170511 0000899243-17-012930.hdr.sgml : 20170511 20170511203039 ACCESSION NUMBER: 0000899243-17-012930 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170510 FILED AS OF DATE: 20170511 DATE AS OF CHANGE: 20170511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Novus Therapeutics, Inc. CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 949-238-8090 MAIL ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc DATE OF NAME CHANGE: 20070622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OCAMPO CHRISTINE CENTRAL INDEX KEY: 0001280154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36620 FILM NUMBER: 17836087 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-10 0 0001404281 Novus Therapeutics, Inc. NVUS 0001280154 OCAMPO CHRISTINE C/O NOVUS THERAPEUTICS, INC. 19900 MACARTHUR BLVD., SUITE 550 IRVINE CA 92612 0 1 0 0 See Remarks Common Stock 2017-05-10 4 P 0 10010 9.99 A 21590 D All numbers give effect to the 1:9 reverse stock split effected by the Company on May 11, 2017. Chief Financial and Compliance Officer /s/ Ryan A. Murr, as attorney-in-fact for Christine G. Ocampo 2017-05-11